Robert Hamilton Pierce serves as Executive at Sensei Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Robert Hamilton Pierce has executed 5 insider transactions totaling $686.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 15, 2022 involved receiving (via award) 21,000 shares valued at $0.
Robert Hamilton Pierce currently holds 21,000 shares of Sensei Biotherapeutics, Inc. (SNSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Hamilton Pierce has been a net seller of SNSE stock. They have purchased $0 and sold $686.0K worth of shares.
Robert Hamilton Pierce's most recent insider trade was on Feb 15, 2022, when they sold 21,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.34 |
| Discretionary |
| Aug 10, 2021 | SNSE | $473.1K | Sale | 66,350 | $7.13 | Discretionary |
| Aug 9, 2021 | SNSE | $49.3K | Sale | 6,982 | $7.06 | Discretionary |
| Aug 6, 2021 | SNSE | $45.9K | Sale | 6,460 | $7.11 | Discretionary |